https://biotechmorning.com/news/scholar-rock-apitegromab-sma-muscle-therapy-fda-approval Biotech Morning en 2026-09-21T14:18:08.632Z The Drug That Treats SMA's Muscle Problem, Not Just Its Genetic One https://biotechmorning.com/news/thyroid-trick-bipolar-depression-elunetirom Biotech Morning en 2026-09-21T14:17:24.444Z The Thyroid Trick That Might Crack Bipolar Depression https://biotechmorning.com/news/bms-nvidia-ai-supercomputer-drug-discovery Biotech Morning en 2026-09-21T14:16:40.436Z BMS Just Bought the Biggest AI Supercomputer in Pharma. Now What? https://biotechmorning.com/news/ionis-zilganersen-zanvastro-fda-approval-alexander-disease Biotech Morning en 2026-09-21T14:15:51.081Z The Disease So Rare It Had Zero Treatments. Until Now. https://biotechmorning.com/news/sleep-drug-aces-adhd-test-alkermes-orexin Biotech Morning en 2026-09-21T14:15:05.707Z A Sleep Drug Just Aced an ADHD Test. Wait, What? https://biotechmorning.com/news/beacon-therapeutics-laru-zova-xlrp-pivotal-win Biotech Morning en 2026-09-21T14:14:18.750Z The Gene Therapy That Could Save Sight for a Disease With Zero Treatments https://biotechmorning.com/news/telix-itm-acquisition-radiopharmaceutical-novartis Biotech Morning en 2026-09-21T14:13:38.333Z Telix Just Wrote a $1.6B Check to Pick a Fight With Novartis https://biotechmorning.com/news/keytruda-trodelvy-tnbc-first-line-fda-approval Biotech Morning en 2026-09-21T14:12:43.752Z The Two-Drug Combo That Just Rewrote the Playbook for Breast Cancer's Worst Villain https://biotechmorning.com/news/novo-nordisk-kallyope-non-incretin-obesity-deal Biotech Morning en 2026-09-21T14:11:55.409Z Novo Nordisk Just Bought an Obesity Playbook That Has Nothing to Do With GLP-1 https://biotechmorning.com/news/transgene-tg4050-perfect-three-year-survival Biotech Morning en 2026-09-20T14:15:14.975Z A Tiny Cancer Vaccine Trial Just Posted a Perfect Score https://biotechmorning.com/news/menarini-innovent-bofanglutide-europe-obesity-deal Biotech Morning en 2026-09-20T14:14:32.289Z Europe's Newest Obesity Drug Comes From a Place You Wouldn't Expect https://biotechmorning.com/news/novo-nordisk-drops-nordisk-rebrand Biotech Morning en 2026-09-20T14:13:43.724Z Why the World's Biggest Pharma Company Just Erased Half Its Name https://biotechmorning.com/news/zealand-pharma-zeydovio-chmp-positive-opinion-europe Biotech Morning en 2026-09-20T14:13:00.663Z Europe's First New Gut Treatment in a Decade Just Cleared a Major Hurdle https://biotechmorning.com/news/fda-expedited-ind-pilot-program-phase-1-trials Biotech Morning en 2026-09-20T14:12:15.779Z The FDA Wants to Stop Losing Its Best Drug Trials to Australia https://biotechmorning.com/news/gsk-hutchmed-hmpl-a830-adc-deal Biotech Morning en 2026-09-20T14:11:26.441Z GSK Just Spent $1.3 Billion on a Drug That Hasn't Entered a Single Patient https://biotechmorning.com/news/roche-simcere-trispecific-deal Biotech Morning en 2026-09-20T14:10:38.629Z Roche Just Paid $1.5 Billion for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/skyhawk-sky-0515-huntington-pill Biotech Morning en 2026-09-20T14:09:49.833Z The Pill That Might Actually Slow Huntington's Disease https://biotechmorning.com/news/astrazeneca-camizestrant-serena4-trial-miss Biotech Morning en 2026-09-20T14:09:04.127Z AstraZeneca's Breast Cancer Pill Had One Job. It Didn't Deliver. https://biotechmorning.com/news/astrazeneca-summit-15-billion-ivonescimab-deal Biotech Morning en 2026-09-20T14:08:24.104Z The $15 Billion Handshake That Could Reshape Lung Cancer